As the global economy grows, obesity has emerged as a significant public health challenge
With time, however, evidence has surfaced to suggest the drug's reach could go far beyond that, meaning metformin might be having an unseen effect in millions of patients worldwide
For most compounded GLP-1 programs, the prescribing clinician makes the decision based on the intake questionnaire and any uploaded labs or photos
In most cases, following the medications safety window or simply waiting until the next scheduled dose is the safest move
Access articles from across Canada with one account Share your thoughts and join the conversation in the comments Enjoy additional articles per month Get email updates from your favourite authors Sign In or Create an Account In the past few months, growth in prescriptions for GLP-1 drugs for weight loss like Novo Nordisk A/S Wegovy and Eli Lilly & Co.s Zepbound have moderated, according to Cigna Group chief executive Brian Evanko